Christopher A. Rice, BSc, PhD
Assistant Professor, Parasitology ; Section Head, Microbiology, Immunology and Molecular Genetics
Dr. Christopher A. Rice grew up as a wee lad in a small coastal town of Irvine, Ayrshire, on the West coast of Scotland. He studied his Higher National Certificate (HNC) and Higher National Diploma (HND) in Biomedical Sciences at Ayrshire college, formerly James Watt College, in Kilwinning in 2007-2008. This is where he developed his interest in Microbiology. He furthered his studies by pursuing a Scottish Bachelor of Science degree with Honours at The University of the West of Scotland (UWS), graduating in 2010 focused on Microbiology and Immunology. He continued his studies at UWS, pursuing a Ph.D. under the direction of Dr. Fiona Henriquez-Mui where he focused his research thesis on “Histidine and Lysine amino acid biosynthesis as antimicrobial targets in Acanthamoeba species”, graduating in 2014.
After graduating with his Ph.D., Chris made a transatlantic journey heading to Tampa Bay, FL to work with Dr. Dennis Kyle at the University of South Florida (USF), go Bulls, as a Postdoctoral Fellow 2014-2016. Here he developed high-throughput colorimetric and luminescent drug screening assays focused on Naegleria fowleri and Acanthamoeba species drug discovery. Continuing the theme of “bulls”, Dr. Kyle moved his lab to the University of Georgia (UGA), Bulldawg territory, in Athens, GA, to become the director of the Center for Tropical and Emerging Global Diseases (CTEGD) in January of 2017. Here, the amoeba team (Chris and Beatrice) continued their drug discovery and development projects through drug repurposing identifying posaconazole as a combinational partner drug for the treatment of primary amoebic meningoencephalitis (PAM), caused by Naegleria fowleri curing in vivo CNS efficacy models from PAM disease. Dr. Rice continued his drug discovery efforts by including Acanthamoeba spp. and Balamuthia mandrillaris to diversify himself from Dr. Kyle’s main research interests on N. fowleri. The amoeba team expanded to four with the inclusion of Emma (2017) and Cassie (2018) joining the amoeba discovery team, focused on N. fowleri projects. In 2019, Dr. Rice was hired as an Assistant Research Scientist and manager of the Center for Drug Discovery at UGA in the College of Pharmacy, Pharmacy and Biomedical Science department. He co-developed the PMCY-6420 course “Computational Approaches in Drug Discovery and Toxicology”, lectured in PMCY-6410 “Robotic Technology in Drug Discovery and Toxicology”, and guest lectured in PMCY-2200 “Pills, Potions, and Drugs in Modern Medicine”.
In August 2022, Dr. Rice was hired at Purdue University as an Assistant Professor of Parasitology in the Department of Comparative Pathobiology and College Veterinary Medicine where he established the Rice Research Group and hired his first Ph.D. student, Chenyang Lu, where she is focused on developing novel Balamuthia mandrillaris diagnostics and continuing drug discovery and development models for this neglected and emerging pathogen.
Beyond work, Dr. Rice enjoys travelling, socialising, and playing video games competitively (Halo series, Fortnite, or Apex).